A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.

McPherson StuartNina WilkinsonDina TiniakosJennifer WilkinsonAlastair D BurtElaine McCollDeborah D StockenNick SteenJane BarnesNicola GoudieStephen StewartYvonne BuryDerek MannQuentin M AnsteeChristopher P Day

Published in: PloS one (2017)

ISRCTN 57849521.

Keyphrases

liver injury
systemic sclerosis
angiotensin ii
idiopathic pulmonary fibrosis
drug induced
liver fibrosis